Literature DB >> 1354791

Pathogenesis of non-insulin-dependent diabetes mellitus in the black population of southern Africa.

B I Joffe1, V R Panz, J R Wing, F J Raal, H C Seftel.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is an important health problem in the black population of southern Africa. Whether the primary cause of NIDDM is insulin secretory dysfunction or peripheral insulin resistance is unknown. In westernised populations it is believed that insulin resistance and hyperinsulinaemia occur in the early stages of disease, followed later by progressive impairment of insulin secretion. However, we suggest that in the southern African black population a decrease in the mass of functioning beta cells is an important event, making these people vulnerable to the deleterious effects of insulin resistance induced by obesity and other factors. These abnormalities are, in turn, associated with insulin receptor down-regulation. An accelerated decline in beta-cell function then follows in susceptible individuals, ultimately producing striking insulinopenia. Insulinopenic NIDDM in black southern Africans may partly explain why this population has a comparatively low incidence of macrovascular complications and also predicts a short-lived therapeutic response to oral sulphonylureas in most patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354791     DOI: 10.1016/0140-6736(92)91777-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study.

Authors:  T Ohmura; K Ueda; Y Kiyohara; I Kato; H Iwamoto; K Nakayama; K Nomiyama; S Ohmori; T Yoshitake; A Shinkawa
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 3.  The pathogenesis of NIDDM.

Authors:  C N Hales
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 4.  Insulin and colon cancer.

Authors:  E Giovannucci
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506

5.  Using central cancer-registry data to monitor progress in early detection of breast and cervical cancer (Illinois, United States).

Authors:  H L Howe; M Lehnherr; R Y Qualls
Journal:  Cancer Causes Control       Date:  1995-03       Impact factor: 2.506

6.  Latent Autoimmune Diabetes Mellitus in Adults (LADA) and it's characteristics in a subset of Nigerians initially managed for type 2 diabetes.

Authors:  Olufunmilayo O Adeleye; Anthonia O Ogbera; Olufemi Fasanmade; Olayinka O Ogunleye; Akinola O Dada; Ayotunde O Ale; Femi M Abatan
Journal:  Int Arch Med       Date:  2012-08-15

7.  Beta cell response to a mixed meal in nigerian patients with type 2 diabetes.

Authors:  Ekenechukwu E Young; Sonny Chinenye; Chioma N Unachukwu
Journal:  BMC Endocr Disord       Date:  2012-06-27       Impact factor: 2.763

8.  Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja.

Authors:  Akinyele Taofiq Akinlade; Anthonia Okeoghene Ogbera; Olufemi Adetola Fasanmade; Michael Adeyemi Olamoyegun
Journal:  Int Arch Med       Date:  2014-11-28

9.  Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women.

Authors:  Julia H Goedecke; Joel A Dave; Mirjam V Faulenbach; Kristina M Utzschneider; Estelle V Lambert; Sacha West; Malcolm Collins; Tommy Olsson; Brian R Walker; Jonathan R Seckl; Steven E Kahn; Naomi S Levitt
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 17.152

10.  Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans.

Authors:  N Chaturvedi; P M McKeigue; M G Marmot
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.